Yahoo Web Search

Search results

1. • 

     2 Beaten-Down Stocks to Buy and Hold for 10 Years

     Motley Fool via Yahoo Finance· 4 hours ago

     Its pipeline features 55 compounds. So, the drugmaker should be just fine over the long run even if it may take some patience before the company fully...

2. • 

     Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution

     Simply Wall St. via Yahoo Finance· 2 days ago

     Many Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...

3. • 

     Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a...

     Simply Wall St. via Yahoo Finance· 6 days ago

     Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs...

4. • 

     Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields -...

     Benzinga· 5 hours ago

     This analyst has an accuracy rate of 70%. Recent News: Organon announced pricing of $1.0 billion...

5. • Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...

     Knox Daily· 1 day ago

     The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol ...

6. • Alpha Metallurgical: Q1 Earnings Snapshot

     Houston Chronicle· 4 days ago

     BRISTOL, Tenn. (AP) — BRISTOL, Tenn. (AP) — Alpha Metallurgical Resources, Inc. (AMR)...

7. • Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)

     ETF DAILY NEWS· 3 days ago

     Fisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent ...

8. • 

     Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Enovis (NYSE:ENOV), Bristol...

     Benzinga· 3 days ago

     The company's stock fell around 17% over the past month. It has a 52-week low of $43.04. RSI Value:...

9. • 

     Catalyst's New CEO Has Big Ideas For The Small Biotech

     Investor's Business Daily· 4 hours ago

     So, we're going to have a different model than other companies might have. Growth Plans Could Buoy...

10. • 

      Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...

      The Fiscal Times via Yahoo Finance· 19 hours ago

      The report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers...